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Abstract
Oxidative stress is a common etiological feature of neurological disorders, although the pathways that govern defence
against reactive oxygen species (ROS) in neurodegeneration remain unclear. We have identified the role of oxidation
resistance 1 (Oxr1) as a vital protein that controls the sensitivity of neuronal cells to oxidative stress; mice lacking Oxr1
display cerebellar neurodegeneration, and neurons are less susceptible to exogenous stress when the gene is over-
expressed. A conserved short isoform of Oxr1 is also sufficient to confer this neuroprotective property both in vitro and in
vivo. In addition, biochemical assays indicate that Oxr1 itself is susceptible to cysteine-mediated oxidation. Finally we show
up-regulation of Oxr1 in both human and pre-symptomatic mouse models of amyotrophic lateral sclerosis, indicating that
Oxr1 is potentially a novel neuroprotective factor in neurodegenerative disease.
Citation: Oliver PL, Finelli MJ, Edwards B, Bitoun E, Butts DL, et al. (2011) Oxr1 Is Essential for Protection against Oxidative Stress-Induced
Neurodegeneration. PLoS Genet 7(10): e1002338. doi:10.1371/journal.pgen.1002338
Editor: Harry T. Orr, University of Minnesota, United States of America
Received May 18, 2011; Accepted August 24, 2011; Published October 20, 2011
Copyright:  2011 Oliver et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kay.davies@dpag.ox.ac.uk
. These authors contributed equally to this work.
Introduction
Reactive oxygen species (ROS) are the natural by-products of
many essential biological processes such as mitochondrial
respiration, although they are also potentially damaging to cells.
Consequently, eukaryotic organisms have evolved a comprehen-
sive range of proteins to detoxify ROS and repair against any
unwanted oxidative damage to DNA, lipids or proteins. These
antioxidants include enzymatic scavengers such as superoxide
dismutase (SOD) and catalase, glutathione peroxidase (Gpx) and
peroxyredoxins, as well as non-enzymatic factors including
glutathione, flavonoids and vitamins [1–2]. Oxidative stress occurs
when the antioxidant response is insufficient to balance the
production of ROS; this state can ultimately cause cell death by
apoptosis or necrosis via an array of signalling pathways, and
many studies both in vitro and in vivo have demonstrated that the
normal function of antioxidant defence systems is vital for cell
survival [3]. For example, mouse knockouts representing the most
critical mitochondrial antioxidant genes are often lethal at the pre-
or early post-natal stage, including glutathione peroxidase 4
(Gpx4), thioredoxin 2 (Thx2) and SOD2 [4–6].
In recent years there has been a particular focus on the role of
ROS in neurons, driven by the consistent presence of various
oxidative stress markers in neurodegenerative disease, as well as
several pathogenic mutations in proteins that feature prominently
in antioxidant pathways [3]. Furthermore, it appears that the
brain is more vulnerable to ROS damage compared to other
organs due to its high metabolic rate combined with a relatively
low concentration of antioxidant proteins [7]. Indeed, oxidative
stress and mitochondrial dysfunction have been implicated in all
major neurodegenerative disorders, including amyotrophic lateral
sclerosis (ALS), Parkinson’s and Alzheimer’s disease (PD and AD)
[3,8–9]; yet, despite numerous attempts to recapitulate human
disease pathology in mouse models, it is unclear how the timing
and disruption of endogenous ROS defence pathways might lead
to such heterogeneous neuropathological features [10]. Conse-
quently, with speculation that the up-regulation of antioxidants
may be a practical therapeutic target for neurological disease [11],
the hunt continues for new proteins that are key players in the
oxidative stress response.
In one such search for human factors induced under oxidative
stress, Volkert et al. identified oxidation resistance 1 (OXR1) as a
novel gene that was able to suppress DNA damage in Escherichia
coli oxidative repair-deficient mutants [12]. They went on to report
that the human protein, when localised to the mitochondria, was
sufficient to prevent oxidative damage in Saccharomyces cerevisiae
mutants lacking Oxr1 [13]. Indeed, the gene is found in all
eukaryote genomes, although in lower organisms its sequence is
restricted predominantly to the highly conserved C-terminal
(TLDc) domain [14]. In humans, the TLDc domain-containing
gene family is composed of four proteins in addition to OXR1,
including nuclear receptor coactivator 7 (NCOA7) and TBC1D24
[14–15]. Significantly, a mutation in the TLDc domain of
TBC1D24 recently has been found in Familial Infantile Myoclonic
Epilepsy (FIME) [16]. The function of this domain has not been
established, yet it was originally identified as a catalytic motif [17].
Studies have demonstrated that Oxr1 is induced under oxidative
stress [13,18]; however, virtually nothing is known about this
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obviously evolutionary significant gene or the TLDc domain itself
in mammalian systems.
Here we have used a combination of in vivo and in vitro
approaches to show that the levels of Oxr1 are critical for neuronal
survival and that up-regulation occurs in both human disease and
mouse models of neurodegeneration. In addition, we demonstrate
that the conserved TLDc domain alone is sufficient to confer
functionality in the mouse. This study therefore reveals the vital
role of Oxr1 in oxidative stress-related neurodegeneration.
Results
Bella mutants display cerebellar neurodegeneration
We identified the recessive Bella (bel) mouse as part of our screen
for mouse models of human movement disorders and ataxia from
a large-scale mutagenesis programme. Bel mice are indistinguish-
able from their control littermates at 2 weeks of age (P14); however
they rapidly develop a severe ataxic gait (see Video S1), fail to gain
weight as quickly as controls, and do not survive beyond P26.
Pathological analysis of the bel CNS revealed significant and
increasing number of apoptotic cells in the granule cell (GC) layer
(GCL) of the cerebellum (Figure 1A and 1B). The onset of cell
death occurs from P18-19, after which there is a highly significant
increase in apoptotic cells in the following days (Figure 1C). No
cell death was observed in any other region of the brain or spinal
cord in end-stage mutants, however (data not shown). The relative
size, structure and foliation pattern of the cerebellum was not
affected in late-stage bel mutants as determined by quantitative
histological methods (Figure S1A, S1D, and S1E) and no
significant difference in the GCL width was observed, reflecting
the relatively small proportion of apoptotic cells in mutant mice
(Figure S1B and S1F). Purkinje cell (PC) death is frequently
associated with GC loss [19–22] therefore the relative density of
PCs was calculated from bel mice, although no reduction was
observed compared to controls (Figure S1C and S1G). Quanti-
tative histopathology of skeletal muscle was also carried out on
end-stage bel mice. A significant increase in centrally nucleated
fibres was observed in the diaphragm of mutants compared to
Figure 1. Progressive neurodegeneration in the bel mutant. (A)
Apoptotic cells are found in the granule cell layer (GCL) but not the
Purkinje cell layer (PCL) or molecular layer (ML) of the bel (bel/bel)
cerebellum from P19 as indicated by TUNEL staining. (B) Cleaved
caspase-3 immunostaining of bel cerebellum at P24 showing positive
neurons in the GCL (arrow). Sections are counterstained with cresyl
violet (Nissl) indicating condensed nuclei, also indicative of apoptotic
cells (arrowhead). (C) Temporal quantification of apoptotic cells in the
bel and heterozygous (bel/+) cerebellum. Mean total number of TUNEL
and caspase-3 positive cells from multiple parasagittal sections of the
whole cerebellum show a large increase in apoptosis at P24. Scale bars:
150 mM (A), 50 mM (B).
doi:10.1371/journal.pgen.1002338.g001
Author Summary
Oxygen is vital for life, but it can also cause damage to
cells. Consequently, protective proteins (antioxidants) are
utilised to maintain the fine balance between oxygen
metabolism and the production of potentially toxic
reactive oxygen species (ROS). If this balance is not
maintained, oxidative stress occurs and excess ROS are
generated, causing damage to DNA, proteins, and lipids.
The brain is particularly susceptible to oxidative stress, and
ROS–induced damage is a common feature of all major
neurodegenerative disorders, including amyotrophic later-
al sclerosis (ALS) and Parkinson’s disease (PD). However,
the molecular mechanisms of ROS defence in neurons are
still under investigation. Here we describe the character-
isation of oxidation resistance 1 (Oxr1), a gene previously
shown to be induced under oxidative stress. We show
both in mice and in cells that loss of Oxr1 causes cell death
and that increasing protein levels can protect against ROS.
In addition, Oxr1 is over-expressed in the spinal cord in ALS
patients, as well as in a pre-symptomatic ALS mouse
model. These data demonstrate for the first time that Oxr1
is vital for the protection of neuronal cells against oxidative
stress and that induction of Oxr1 may be relevant to
neurodegenerative pathways in disease.
Oxr1 Protects against Oxidative Stress in Neurons
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controls, indicative of muscle degeneration, but not in the tibialis
anterior (TA) or soleus muscles of the hindlimb (Figure S1H and
S1I). Heterozygous (bel/+) mice aged up to 18 months of age
display no neuropathological or gait abnormalities (data not
shown).
Bel mice contain a 193.5 kb genomic deletion spanning
the Oxr1 gene
An initial genome scan followed by further genetic mapping
using polymorphic microsatellite and SNP markers reduced the
critical region containing the bel mutation to 5.5 Mb on
chromosome 15. Unexpectedly, during candidate gene sequenc-
ing, exons representing the genes Oxr1 and Muscle Activator of
Rho Signalling (STARS or Abra [23]) could not be amplified from
bel DNA. Therefore, genomic walking using chromosomome 15-
specific PCR primers followed by inverse PCR was used to identify
the boundaries of the apparent spontaneous deletion; the missing
region was confirmed as 193.5 kb, ablating the expression of both
Oxr1 and Abra (Figure S2A and S2B). To confirm no additional
ENU-generated mutation was segregating with the bel phenotype,
all annotated coding and non-coding transcripts in the critical
region were sequenced and no mutations were identified. In
addition, qRT-PCR confirmed that the loss of potential regulatory
sequences did not influence the expression of all adjacent
transcripts within the bel critical region (data not shown).
Oxr1 is highly expressed in the developing postnatal CNS
Expression studies were then carried out to determine the
distribution of both deleted genes in the central nervous system
(CNS). In situ hybridisation and RT-PCR showed that while Oxr1
was expressed in the cerebellar GCL, Abra could not be detected in
the cerebellum or the rest of the brain (Figure 2A and Figure S3D).
Further analysis of the developmental expression patterns showed
that Oxr1 is highly expressed in all major regions of the postnatal
brain and spinal cord at the RNA level (Figure 2B and Figure
S3A), although Abra could only be detected in skeletal muscle tissue
by in situ hybridisation and RT-PCR (Figure S3B and S3D); these
data are consistent with previously published expression data on
both genes [13,23]. In the mouse, several isoforms of Oxr1 have
been described, including the shortest isoform that includes only
the TLDc domain-containing exons 10 to 16 (or 11 to 16) with a
unique first exon (exon 9) (Oxr1-C, also known as C7C [24]; for
detail see Figure S7 and Figure S3C). In situ hybridisation using
isoform-specific probes demonstrated that both the Oxr1-C and
full-length (Oxr1-FL) transcript variants showed an essentially
identical expression pattern (Figure S3E), in agreement with the
riboprobe common to both isoforms used above (Figure 2B). An
antibody raised against the same common C-terminal end of Oxr1
(Figure S7) confirmed high levels of Oxr1 protein in the brain,
with no signal in bel tissue as expected (Figure 2C); these data also
serve to demonstrate the specificity of the antibody. Taken
together, these data suggest that loss of Oxr1 and not Abra is
responsible for the neuropathology observed in bel mutants.
The bel phenotype is rescued by an Oxr1 transgene
As conclusive proof that deletion of Oxr1 causes the bel
phenotype, we performed a genetic rescue experiment with two
independent Oxr1 transgenic lines. Ubiquitous expression of the
full-length Oxr1 cDNA (Oxr1-FL) in the brain was confirmed by
in situ hybridisation in bel mutants carrying the transgene (bel/bel;
Tg(CAG-Oxr1)+/2) (Figure 3A). Animals of this genotype displayed
no ataxia or growth defects, and no cell death was detected in any
region of the brain, including the cerebellar GCL, compared to
littermates that did not contain the Oxr1 transgene (bel/bel;
Tg(CAG-Oxr1)2/2) (Figure 3B). This rescue of the bel phenotype is
maintained in bel/bel; Tg(CAG-Oxr1)+/2 mice aged to 8 months of
age (Figure 3B). These data confirm that neurodegeneration in bel
mice is caused by Oxr1.
Oxr1 levels control the susceptibility of granule cells to
oxidative stress
To demonstrate that loss of Oxr1 rendered neurons from bel
mice more vulnerable to ROS, primary GCs were assayed for
hydrogen peroxide (H2O2) sensitivity. The assay conditions were
first optimised to facilitate measurements of cell death in the
presence or absence of Oxr1 (Figure S4A). These data confirmed
Figure 2. Oxr1 is absent in bel mice but highly expressed in the
wild-type postnatal brain. (A) In situ hybridisation showing the
presence of Oxr1 but not Abra in the GCL of the cerebellum in P24
heterozygous (bel/+) mice, whereas bel mutants lack both genes. (B)
Oxr1 expression in parasagittal sections from wild-type adult and
postnatal brain by in situ hybridisation. (C) Western blot of Oxr1 from
whole brain tissue of mice of each genotype in the bel genetic cross;
the full-length protein is at approximately 85 kDa and smaller isoforms
are observed at approximately 55 and 40 kDa. Note that the specificity
of the antibody is also demonstrated by the lack of signal in tissue from
bel mice. Scale bar: 150 mM (A).
doi:10.1371/journal.pgen.1002338.g002
Oxr1 Protects against Oxidative Stress in Neurons
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that bel mutant GCs are significantly more susceptible to
exogenous peroxide-induced apoptosis than controls (Figure 4A).
To further investigate the specificity of this effect, all Oxr1 isoforms
were then knocked-down by an shRNA to ,10% of endogenous
levels in wild-type GCs, resulting in almost twice the level of cell
death compared to neurons transfected with control constructs
(Figure 4B and Figure S4B). Conversely, replacement of Oxr1 in
bel GCs by lentiviral expression rescued the level of apoptotic cell
death in H2O2-treated cells down to wild-type levels (Figure 4C
and Figure S4B); thus once again strongly suggesting that loss of
Oxr1 alone is responsible for the bel phenotype. Significantly,
lentiviral over-expression of Oxr1 in wild-type GCs lead to a
significant reduction in apoptosis compared to cells expressing
endogenous levels of the gene (Figure 4C and Figure S4B),
demonstrating that Oxr1 can also be protective to neurons
exposed to stress.
In bel end-stage mice, apoptotic cell death is specific to the
cerebellar GCL, despite high levels of expression in other brain
regions including the wild-type cortex (Figure 2B). To therefore
investigate whether loss of Oxr1 would also render non-cerebellar
neurons susceptible to oxidative damage, we assayed cell death in
primary cortical cells (CCs) from bel mice in parallel with
cerebellar GCs; both cell populations were cultured to correspond
to P14 and P21 in vivo, respectively (Figure 4D). These data show
that no increase in cell death occurs in response to peroxide
treatment in bel GCs after 7 days in culture; however, after 14 days
of culturing a significant increase in apoptosis (approximately
80%) is observed in mutant cells versus wild-type. Although similar
results were obtained from CCs, interestingly a much smaller
increase in cell death is seen (approximately 20%) in mutants at
the second timepoint (Figure 4D). This suggests that in the
cerebellum Oxr1 levels play a more defining role in neuronal
survival, consistent with the specificity of neurodegeneration in bel
mice.
Previous studies have described the presence of OXR1 in the
mitochondria of HeLa cells [13], but also in the nucleus and
nucleolus in other mammalian cell lines using a different antibody
[24]. Thus to clarify the localisation of Oxr1 in neuronal cells,
immunofluorescence was carried out in wild-type GCs. Using our
antibody, Oxr1 was not detectable in GCs unless the cells were
treated with H2O2, which clearly induced protein expression
(Figure S4C). In these treated cells, Oxr1 also co-localised with the
mitochondrial marker Cox4, consistent with published studies
[13]. To determine whether similar induction and localisation was
common to other neuronal cell lines, the localisation studies were
repeated in N2A cells, generating essentially identical results
(Figure S4C). These data demonstrate stress-induction and
predominantly mitochondrial localisation of Oxr1 in neurons.
Loss of Oxr1 induces oxidative DNA damage
In view of the link between Oxr1 and oxidative stress, we then
screened for markers of oxidative stress in bel mice. 8-OHdG
staining was detected exclusively in the mutant GCL at P24,
indicative of oxidative DNA damage (Figure 5A). In agreement
with the apoptotic markers, virtually no DNA damage was
detectable prior to P24 (Figure 5B). To further quantify DNA
fragmentation due to loss of Oxr1, the DNA strand scission factor
from GCs was calculated using a picogreen assay, showing a
significant increase in DNA breaks in bel GCs subjected to H2O2
treatment (Figure 5C). We then analysed a large range of both
direct and indirect markers of oxidative stress in addition to
antioxidant enzymes from the cerebellum of end-stage (P24) bel
mice by qRT-PCR (Figure S5A). These data identified an
approximate 70% reduction in expression of glutathione perox-
idase 1 (Gpx1) in mutants, although no other genes showed
significant differences between the genotypes (Figure S5A and
S5B). We went on to test key antioxidants at the protein level, but
found no deregulation of the protein expression or enzyme
Figure 3. Genetic rescue of the bel phenotype with an Oxr1 transgene. (A) In situ hybridisation of Oxr1 from littermates at P24 shows the
ubiquitous expression of the Oxr1 transgene (from bel/bel Tg(Oxr1)/+ sections) in the brain. Two independent lines of bel/bel Tg(Oxr1)/+ ‘rescue’ mice
display no ataxia and no apoptotic cell death in the cerebellum as shown by TUNEL staining (B) compared to control bel mice that do not express the
transgene (bel/bel+/+), demonstrating that replacement of Oxr1 is sufficient to rescue the bel phenotype. Scale bars: 2 mm (A), 150 mM (B).
doi:10.1371/journal.pgen.1002338.g003
Oxr1 Protects against Oxidative Stress in Neurons
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activities of Gpx or catalase in the bel cerebellum (Figure S5C,
S5D, S5E). Using the same assays, there was no evidence for
oxidative stress in brain regions outside of the cerebellum (data not
shown). These data combined with the 8-OHdG results suggest
that the bel cerebellum does show some signs of oxidative stress
response due to the loss of Oxr1; although these are clearly limited
in vivo by the relatively small proportion of neurons affected in end-
stage mutant animals.
The cellular and tissue data combined suggest that the effect of
Oxr1 deletion is highly specific to GCs in bel mice in vivo. We
therefore investigated whether Oxr1 may also influence sensitivity
to other cellular stress factors using serum starvation in cultured
GCs. These data show that there was a significant (approximately
7-fold) increase in apoptosis in GC neurons cultured without
serum, although no difference in the levels of cell death was
observed between bel and control GCs (Figure S6). These data
suggest that loss of Oxr1 does not influence sensitivity to all cellular
stress conditions.
The conserved TLDc domain of Oxr1 is sufficient to
confer protection against oxidative stress
As discussed above, the C-terminal TLDc domain is highly
conserved in all Oxr1 orthologues as well as being highly
Figure 4. Oxr1 regulates sensitivity of GC neurons to oxidative
stress. (A) GCs from P7 bel (bel/bel) mice cultured for 14 days show a
significant increase in apoptotic cell death compared to wild-type (+/+)
when subjected to peroxide treatment. (B) Similar results to bel GCs are
obtained under the same conditions in wild-type GCs transfected with
an Oxr1 shRNA knockdown construct, in contrast with mock transfected
(pLKO.1puro) and scrambled shRNA transfected (scr. shRNA) cells. (C)
Expression of Oxr1 in bel GCs is sufficient to rescue the peroxide
sensitivity and protect wild-type GCs from the same treatment. (D)
Primary bel GCs neurons subjected to H2O2 treatment demonstrate a
relative increase in peroxide sensitivity compared to cortical cells (CC)
when cultured to represent the same P14 and P21 timepoint. Note that
no significant difference in sensitivity to peroxide treatment is observed
in GCs after 7 days of culture between bel and wild-type mice,
consistent with the lack of cell death observed in bel mice at P14. (A–D)
Asterisks indicate statistical significance (*P,0.05, **P,0.01 and
***P,0.001; ANOVA).
doi:10.1371/journal.pgen.1002338.g004
Figure 5. Oxidative DNA damage in bel GCs. (A) 8-OHdG
immunostaining of cerebellum sections at P24 showing oxidative
DNA damage in the GCL of bel mice (arrowhead). (B) Temporal
quantification of 8-OHdG immunostaining from parasagittal sections of
the whole cerebellum showing a large increase in positive cells at P24 in
bel mice. (C) DNA fragmentation from cultured primary GCs quantified
by picogreen. A significant increase in DNA damage is seen in peroxide
treated GCs from bel mice compared to controls (**P,0.01; ANOVA).
Scale bar: 50 mM (A).
doi:10.1371/journal.pgen.1002338.g005
Oxr1 Protects against Oxidative Stress in Neurons
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expressed in the brain (Figure S3D). To therefore investigate
whether the short Oxr1-C isoform was functional in neurons, we
repeated the peroxide sensitivity assays in bel GCs using constructs
coding for this isoform as well as Oxr1-FL. In these experiments, a
bicistronic vector containing GFP was used to assay the proportion
of transfected cells that were apoptotic (Figure 6A). These data
show that, despite the removal of over 500 amino-acids from the
N-terminus, Oxr1-C is able to confer protection against oxidative
stress as efficiently as the full-length protein in both wild-type and
bel GC culture.
To determine whether the presence of only short Oxr1 isoforms
would be detrimental to neuronal survival in vivo, a gene-trap
mouse (Oxr1Gt(RRR195)Byg) was rederived containing the vector
insertion between exons 3 and 4 of Oxr1 (Figure 6B and Figure
S7); mice carrying two copies of this insertion are therefore
expected to only express shorter isoforms of the gene. Mice
homozygous for the insertion were successfully generated and the
exact position of the trap vector confirmed (Figure 6B). These mice
displayed no gait or pathological abnormalities in the CNS up to
12 months of age (data not shown) and western blotting confirmed
that the gene-trap insertion had almost completely ablated the
expression of Oxr1-FL as expected (Figure 6C). Interestingly, the
proportion of the smallest isoform (Oxr1-C at approximately
25 kDa) was much higher in these cerebellar extracts than in
whole brain (Figure 6C and Figure 2C); this is consistent with the
isoform-specific in situ hybridisation data (Figure S3E) and suggests
that Oxr1-C may play a more significant functional role in the
cerebellum than other regions of the CNS. These data
demonstrate that TLDc domain-containing Oxr1 isoforms other
than the full-length protein are functional.
Oxr1 is susceptible to oxidation by peroxide
To gain some insight for the first time into the mechanism of
Oxr1 function, taking into account the results from peroxide stress
experiments in GCs, we investigated whether Oxr1 could react
directly with H2O2. Recombinant Oxr1-C protein was purified
(Figure S8A) and an Amplex Red assay was used to quantify
decreasing H2O2 concentration in the presence of increasing
concentrations of Oxr1-C. These data demonstrate that Oxr1-C is
able to significantly decrease the H2O2 levels in a dose-dependent
manner (Figure 7A). As a negative control, the same assay was
carried out in the absence of horseradish peroxidase (HRP) that is
an essential part of the Amplex Red reaction. These data show no
change in Amplex Red signal in the presence of Oxr1-C,
suggesting that Oxr1 is not able to compensate for the HRP
activity in this assay and is therefore unlikely to possess peroxidase
activity.
We next examined whether these data could be due to direct
oxidation of the Oxr1 protein. Several amino-acids have the
potential to undergo oxidative modification [25], but we began by
analysing the oxidation state of cysteine residues considering that a
C-terminal cysteine in the TLDc domain is conserved in Oxr1-
and Ncoa7-related sequences found in human, mouse, fly and
yeast (Cys753 in mouse Oxr1; Figure S8B). To quantify the
oxidation of sulfhydryl (SH) side chains, recombinant wild-type
Oxr1-C protein was incubated with H2O2 and then reacted with
ThioGlo-1, a thiol-active fluorophore [26]. Samples were then
separated by gel electrophoresis followed by densitometric analysis
(Figure 7B and 7C). These data show that a significant loss of thiol
labelling in Oxr1-C of approximately 2-fold occurs in the presence
of H2O2, indicating that oxidation of free SH groups is taking
place. To further examine the significance of cysteine residues in
the TLDc domain of Oxr1, the conserved cysteine was mutated
(C753A) and the recombinant protein assayed as above (Figure 7B
and 7C and Figure S8A). Independently, a second cysteine found
in Oxr1 proteins in vertebrates but not the related Ncoa7 was also
mutated and analysed (C704A; Figure 7B and 7C, Figure S8A).
Peroxide-treated C704A Oxr1-C showed a similar 2-fold reduc-
tion in ThioGlo-1 labelling as wild-type Oxr1-C; however, the
C753A mutant protein showed a non-significant loss of fluores-
cence, suggesting that this particular cysteine is more important for
the oxidation state of Oxr1 than C704 (Figure 7B and 7C). As a
Figure 6. The shortest TLDc domain-containing Oxr1 isoform is
able to confer resistance to oxidative stress in vitro and in vivo.
(A) GCs were cultured as above and transfected with Oxr1-FL or –C
constructs in an IRES-GFP expression vector. After peroxide treatment,
the proportion of cells successfully transfected (GFP positive) that were
apoptotic was calculated, showing that both constructs were as
effective at preventing cell death in both wild-type (+/+) and bel GCs
(***P,0.001; ANOVA). (B) Position of the RRR195 gene-trap insertion
(pG10lxf vector), 488 bp from the end of Oxr1 exon 3, as determined by
PCR. (C) Western blot of cerebellar tissue from littermates in the gene-
trap cross showing that in homozygous mice the Oxr1-FL isoform at
approximately 85 kDa is barely detectable, whereas Oxr1-C is
unchanged.
doi:10.1371/journal.pgen.1002338.g006
Oxr1 Protects against Oxidative Stress in Neurons
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positive control for these studies, DJ-1 (PARK7), a protein that has
been well-studied with respect to cysteine oxidation [27–28], was
analysed in parallel (Figure S8A). Recombinant wild-type mouse
DJ-1 showed a similar reduction in ThioGlo-1 labelling upon
peroxide treatment to wild-type Oxr1-C (Figure 7B and 7C).
To ascertain the rate of the reaction between wild-type Oxr1
and H2O2, direct kinetic measurements using HRP competition
assays were attempted [29], but the apparent low levels of
reactivity between Oxr1-C and peroxide rendered this approach
impractical (data not shown). Therefore, ThioGlo-1 labelling
experiments were repeated over a time-course, generating a rate
constant of Oxr1-C oxidation by H2O2 of 0.82 M
21?s21 based on
second-order kinetics (Figure 7D). To then relate the significance
of the cysteine mutants to consumption of H2O2 in the Amplex
Red assay, both were assayed as above in parallel with wild-type
Oxr1-C recombinant protein. In agreement with the thiol
labelling assay, the C753A mutant showed a non-significant level
of peroxide consumption, whereas a significant drop in fluores-
cence was observed using the C704A Oxr1-C mutant (Figure 7E).
In summary, these data suggest that Oxr1 can react directly with
H2O2, although primarily through the oxidation reactive cysteine
residues.
Oxr1 is over-expressed in ALS and in an ALS model
Considering the numerous links between oxidative stress and
neurodegenerative disorders, and the high levels of Oxr1 in the
spinal cord (Figure S3A), we then analysed OXR1 expression in
ALS human biopsy samples. Western blots of ALS spinal cord
tissue show an obvious up-regulation of the intermediate TLDc-
domain-containing OXR1 isoforms compared to age-matched
controls (Figure 8A). As these data were obtained from patients at
the end-stage of disease, it was also important to ascertain whether
up-regulation of Oxr1 occurs before any major neuropathological
changes. Therefore, we analysed protein levels in spinal cord tissue
from pre-symptomatic low-copy G93A mutant superoxide dis-
mutase 1 (SOD1) expressing transgenic mice, a model of ALS.
These data show a significant up-regulation of Oxr1 in SOD1
mutants at 5 months of age compared to littermate controls
(Figure 8B and 8C). Importantly, this represents a timepoint prior
to the first reported signs of neuropathology or oxidative stress in
this particular line [30–31], suggesting that Oxr1 may be a novel
early marker of specific neurodegenerative pathways.
Discussion
Combining results from three mutant mouse lines, cellular
assays and biopsy samples, we have demonstrated for the first time
the importance of Oxr1 in neuronal survival; indeed, our data
Figure 7. Oxr1 undergoes oxidation by H2O2. (A) Purified Oxr1-C
was incubated with H2O2 (1.4 mM) and the remaining H2O2 in the
reaction was determined by the absorbance at 580 nm using an
Amplex Red assay. The graph shows a reduction in residual H2O2 with
increasing recombinant Oxr1-C concentration; from 20 mg/ml of protein
there is a significant decrease in absorbance in the presence of HRP (+
HRP). In the absence of HRP (2 HRP) there is no corresponding
reduction in absorbance. Control (PBS) reactions contained no protein
extract (**P,0.01; ANOVA). (B) Representative in-gel fluorescence of
ThioGlo-1 labelled recombinant Oxr1-C proteins and DJ-1. Proteins were
subjected or not to H2O2 treatment as indicated (100 mM, 30 minutes).
A significant reduction in fluorescence due to loss of free SH groups by
oxidation of cysteine residues was observed in wild-type (WT) Oxr1-C,
C704A Oxr1-C and DJ-1, but not the C753A mutant (quantified in (C);
*P,0.05; **P,0.01; ANOVA). Control reactions (CTRL) contained no
protein extract but included the ThioGlo-1 reagent as a measure of
background fluorescence. Lower panel shows staining of the same
PAGE gel post-analysis to confirm equal loading. (D) ThioGlo-1 labelling
of wild-type Oxr1-C in the presence of H2O2 was quantified over a time-
course to generate a second-order rate constant for the oxidation of
Oxr1 (see Materials and Methods for details). (E) The Amplex Red assay
was repeated (as panel A) using 20 mg of each recombinant Oxr1-C
protein as indicated. No significant reduction in residual H2O2 was
observed when using C753A mutant Oxr1 in the presence of HRP
compared to the corresponding – HRP control (**P,0.01; ANOVA).
Control reactions (CTRL) contained no protein extract.
doi:10.1371/journal.pgen.1002338.g007
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show that the sensitivity of neurons to exogenous stress can be
exquisitely controlled by the level of Oxr1 expression. Oxr1
therefore has much in common with some of the most important
antioxidants [3]; proteins such as SOD2 can be lethal when
disrupted but neuroprotective when over-expressed in vivo and
have therefore been nominated as potential therapeutic targets in
neurodegenerative disease [6,32]. Other key mitochondrial
proteins have also been linked to ataxia in mouse models.
Apoptosis-inducing factor (Aif) is vital to oxidative phosphoryla-
tion, and an 80% reduction in expression of the gene in the
Harlequin (Hq) mutant causes ataxia and oxidative stress-related
GC loss [33]. The Hq phenotype is far less severe than bel,
however, with the first signs of apoptosis in the cerebellum not
appearing until 4 months of age, followed by necrotic Purkinje cell
death and degeneration of other brain regions [19,34].
These models, along with bel mutants, emphasise that the brain
is clearly vulnerable to oxidative stress. Taken further, the fact that
GCs are more susceptible to ROS insults than other neuronal
populations, as observed in bel and Hq mice [33], has been
considered recently in detail. Using a combination of expression
and biochemical data, Wang et al. discovered that cerebellar GCs
were more susceptible to exogenous oxidative stress than neurons
from the cerebral cortex or hippocampal CA3 region [35]. Lower
expression of energy generating genes, combined with a greater
depletion of stored ATP, was also observed in GCs versus stress-
resistant neurons; this suggested that a shortfall in the energy
required to carry out cellular repair might render GCs particularly
sensitive to ROS. These data may also explain why we observed
that bel cortical cells were less sensitive to peroxide treatment than
GCs from bel mice. Neurodegenerative disease often presents with
highly specific pathological lesions despite widespread or ubiqui-
tous expression of the mutated gene(s) involved. Therefore,
examples of selective neuronal vulnerability to oxidative stress,
such as bel, are vital to understand why certain neurons are
targeted while others are spared, particularly in the early stages of
disease [36].
Several splice variants of Oxr1 have been described previously,
although we are the first to show that the shortest of these, Oxr1-
C, is able to protect neurons from oxidative stress as efficiently as
the full-length (Oxr1-FL) protein. Our western blot data is also the
first to demonstrate what appears to be a complex differential
distribution of Oxr1 isoforms at the protein level. For example,
Oxr1-C (25 kDa) is present in the whole brain at very low levels,
although in the cerebellum this splice variant is as highly expressed
as Oxr1-FL (85 kDa) whereas other intermediate isoforms are
absent. As Oxr1 in the apparently normal gene-trap mouse is
almost exclusively represented by the short Oxr1-C protein, we
postulate that Oxr1-C plays a more important role in the response
of GCs to stress than elsewhere in the CNS. Therefore, loss of this
particular isoform as well as the full-length protein, combined with
the apparent vulnerability of GCs, leads to cerebellar-specific
apoptotic cell death in bel mice. Original descriptions of human
OXR1 induction by oxidative stress were restricted to interme-
diate isoforms (at approximately 40 and 58 kDa), based on known
splice variants starting upstream of, but including, the TLDc
domain [12–13]. Although the full-length protein was therefore
not addressed in these early experiments, a construct representing
the 40 kDa isoform was still able to confer protection against ROS
in yeast [13]. Importantly, these original studies are in agreement
with our investigation that unequivocally demonstrates that these
shorter splice variants, all containing the TLDc domain, are
indeed functional.
We chose ALS to model the in vivo induction of Oxr1 as
oxidative stress has been consistently implicated in the human
disease and in ALS mouse models, with multiple markers of
oxidative damage observed in ALS post-mortem tissue recapitu-
lated in SOD1 transgenic lines [37]. The striking up-regulation of
intermediate OXR1 isoforms we observed in ALS may be a
consequence of significant neurodegeneration in the spinal cord;
but crucially, full-length Oxr1 protein levels were significantly
increased in SOD1 G93A mice before any overt phenotypic
abnormalities, suggesting Oxr1 may be an early marker of
neurodegeneration [30–31,38–39]. The fact that alternate iso-
forms were differentially regulated between human and mouse
may reflect species-specific post-transcriptional regulation of Oxr1
or the dissimilar stages of disease examined.
In summary, it is likely that alternate Oxr1 isoforms have
specific purposes; however it is clear from our work that
deciphering the function of the highly conserved TLDc domain
will be key to understanding the role of Oxr1 and Oxr1-related
proteins [14]. In view of this, we assayed recombinant Oxr1-C in a
peroxide scavenging assay and discovered that this region of the
protein can react directly with H2O2 in vitro. This is the first direct
evidence that the TLDc domain, originally predicted to be
catalytic [17], may act as an antioxidant protein. Consequently,
neurodegeneration in bel mice may be due to an increase in ROS
that would normally be detoxified by Oxr1. Importantly, however,
the calculated rate constant for Oxr1 oxidation by H2O2 argues
Figure 8. Expression of Oxr1 in ALS and ALS-related neurodegeneration. (A) Western blot showing up-regulation of OXR1 in thoracic spinal
cord biopsy samples from ALS patients versus age-matched controls. (B) Representative western blot demonstrating the expression of Oxr1 from the
lumbar enlargement of spinal cord tissue from pre-symptomatic SOD1 G93A low-copy transgenic mice and (C) quantification of full-length Oxr1
(85 kDa), n= 6 each genotype (**P,0.01; ANOVA).
doi:10.1371/journal.pgen.1002338.g008
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against a vital role for the protein as an antioxidant enzyme.
Although the value of 0.82 M21?s21 for Oxr1 is of the same order
of magnitude as reactive cysteine-mediated oxidation of BSA and
DJ-1 [28,40], it is thousands of times lower than key antioxidants
such as catalase and peroxiredoxins that have reported oxidative
rate constants of over 107 M21?s21 [29,41–42]. Therefore,
although one attribute of Oxr1 may be to reduce ROS directly,
it appears more likely that the oxidation of Oxr1 itself as a
consequence of oxidative stress in the cell has a more important
functional and/or regulatory role. Such redox-controlled modifi-
cations are important for a variety of proteins, including the
regulation of conformational changes, often related to the
formation or alteration of disulphide bonds [43,44]. For example,
detailed studies of oxidised forms of DJ-1 have focussed on Cys106
as a key residue that mediates the function of the protein, although
the mechanistic link between oxidation of this particular amino-
acid and the multiple proposed roles for DJ-1 in vivo is still unclear
[27]. It will therefore be important in the future to ascertain the
relationship between our data regarding cysteine oxidation of
Oxr1 with three-dimensional structural information of the TLDc
domain; for instance, differences in the accessibility of Cys753 and
Cys704 to peroxide may go some way to explain the results
described here.
A recent study, utilising Oxr1 knockdown in the mosquito
A.gambiae, proposed that Oxr1 down-regulates the transcription of
the antioxidants catalase and Gpx downstream of the stress-related
Jun N-terminal kinase (JNK) [45]. Our transcriptional analysis of
oxidative stress-related genes in the bel cerebellum also identified a
significant reduction in Gpx1 expression, although this difference
was not recapitulated at the protein level or using quantitative
enzyme assays. This is most likely due to the small number of GCs
affected in end-stage bel mice. As the study in A.gambiae was limited
to transcriptional data, it would be interesting to examine whether
the expression changes observed in mosquitoes equate to
detectable alterations at the protein level. Although the interaction
between Oxr1 and antioxidant enzymes is a plausible functional
hypothesis, no mechanism for this particular pathway was
investigated. Indeed, our biochemical data suggest that Oxr1
can react directly with ROS, although an indirect influence on
other antioxidants, such as Gpx, cannot be ruled out.
In the bel cerebellum, further evidence for oxidative stress was
shown by the large increase in oxidative DNA damage as
quantified by 8-OHdG immunostaining. The fact that few
markers for the oxidative stress response were altered overall
may simply reflect the limited lifespan of the bel mutant; only a
small proportion of neurons undergo apoptosis before death
(approximately 1–2% of all GCs) indicating the relative subtlety of
the neuropathology. We can only speculate that if bel mice
survived for longer whether additional regions of the CNS would
be similarly affected. Future work using conditional or inducible
disruption of Oxr1 will shed further light on such region-specific
mechanisms.
The bel mutant is an important new model of oxidative stress-
related neurodegeneration, although the short lifespan of mutants
limits the study of non-cerebellar neurons in vivo. Importantly,
however, the fact that Oxr1 is expressed in all major regions of the
brain and spinal cord, combined with our data from ALS and
SOD1 mutant tissue, suggests that it plays a widespread and vital
neuroprotective role. Indeed, it is intriguing that down-regulation
of OXR1 has been recently reported as one of the major differences
in a microarray study of the cortex in PD [46]. It is frequently
postulated that stimulating endogenous defence pathways would
be an effective strategy in combating cell death in disease [9]; our
findings therefore provide the first indication that the enhance-
ment of Oxr1 activity in vivo may counteract or even prevent the
damage carried out by ROS in the progression of neurodegen-
erative disorders. The apparent functional compensation of
OXR1 between yeast and human [13] and the high degree of
sequence conservation at particular amino acid residues in the
TLDc domain can now be investigated further to help decipher
the molecular mechanisms involved. Indeed, it is noteworthy that
the alanine mutated in the TLDc domain of the TBC1D24
protein in human FIME is not only conserved in OXR1 (Figure
S8B), but has also been shown to inhibit neurite outgrowth in vitro
[16], suggesting that further study into this family of proteins will
also be important for neurological disorders outside of those
directly linked with oxidative stress [47].
Materials and Methods
Ethics statement
All experiments were performed in accordance with the UK
Home Office regulations and approved by the University of
Oxford Ethical Review Panel.
Cloning of the bel deletion
The bel phenotype was first identified from a screen for recessive
ENU mutants at MRC Harwell, UK. To genetically map the trait,
13 bel mutants were initially screened for polymorphic SNP
markers between the parental C3H/HeH and BALB/c (ENU
treated) strains followed by fine mapping using additional
microsatellite and SNP markers. Inverse PCR was carried out
by digesting bel genomic DNA with a range of restriction enzymes,
ligating the products, amplifying around the circular DNAs using
nested primers and sequencing. A BglII restriction fragment
spanning the deletion was consistently identified, which was
confirmed using bel-specific PCR primers (59 CGACTAGGC-
CATCTTCTATTAC and 59 GCTAATGGCTGCCGAGTT-
TG). Mice were genotyped using these deletion primers in
combination with wild-type control primer (59 GTGACTG-
GAGGTGAGCTTTG) or using D15Mit229, a polymorphic
microsatellite marker in very close proximity to the bel deletion.
In situ hybridisation
In situ hybridisation was carried out as previously described on
12 mM frozen tissue sections [48]. Regions of Oxr1 and Abra mouse
cDNA sequences (see Figure S7) were subcloned into pCR4-
TOPO (Invitrogen) prior to DIG-labelled riboprobe synthesis and
hybridisation. Slides were exposed for 16 hours in all cases.
Immunohistochemistry and histology
TUNEL staining for apoptotic cells was carried out on frozen
sections using the in situ cell death kit (Roche). Antibodies for
cleaved caspase-3 (Cell Signalling, 1:500 dilution, 24 hours at 4uC)
and 8-OHdG (QED Biosciences, 1:250) immunostaining were
used on 4% paraformaldehyde perfused, paraffin wax embedded
sections; 8-OHdG staining was carried out as previously described
[49]. Primary antibody staining was visualised using Vectastain
Elite ABC kit (Vectorlabs) or Alexa Fluor 488 or 594 secondary
antibodies (Invitrogen) for immunofluorescence.
Quantitative histopathology
Five 10 mm sections taken at 40 mm intervals from the midline
of 3 bel/+ and 3 bel/bel mice were stained with cresyl violet. The
total area of each section corresponding to the cerebellum and the
remainder of the brain was calculated using Axiovision 4.6
software (Zeiss) and averaged over each genotype. For GCL
analysis, the midpoint of lobes III, IV/V and IX was determined
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as the distance between the apex to the abyss of the fissure. A
region representing 0.4 mm, 0.2 mm either side of this midpoint,
was used to determine the GCL width by dividing the area of the
GCL in this region by 0.4 mm to obtain an average value for each
lobe. To examine Purkinje cell numbers, adjacent sections, 5 from
each animal, were immunostained using anti-calbindin 28 K
(Swant, 1:15000 dilution, 48 hours at 4uC) as previously described
[48]. The total number of Purkinje cells on each section was
counted and divided by the total length of the Purkinje cell layer.
Adjacent sections to those above were used to count caspase-3 and
8-OHdG immunopositive cells in all cerebellar lobes. Quantifica-
tion of apoptosis by TUNEL staining was carried out on five
10 mm midline sections at 40 mM intervals from 3 mice of each
genotype. For muscle histopathology, tissue samples were dissected
and snap frozen in OCT (VWR) on isopentane in liquid nitrogen.
Frozen transverse sections were cut at 10 mM for haematoxylin
and eosin (H&E) staining using standard methods. Counts of
centrally nucleated fibres were averaged from H&E stained
sections from 4 mice of each genotype.
Primary neuronal culture
Culturing of granule and cortical cell cultures was carried out as
previously described (Amaxa Nucleofector protocol (Lonza) and
Bilimoria et al. [50]. Bel mutant and control granule or cortical
neurons were obtained from postnatal day 7 (P7) or P2 animals,
respectively, and cultured for 7 to 19 days prior to treatment. For
cell death experiments, cells were treated with 150 mM H2O2 for
4 hours before being fixed in 4% paraformaldehyde for 15 min-
utes prior to using the TUNEL assay as above. Cells were assayed
for survival by counting 1,500 cells for granule cells or 500 cells for
cortical cells. For immunofluorescence, GCs and N2As were
treated with 1 mM H2O2 for 30 minutes prior to recovery in fresh
media for 1 hour. Cell counts were analyzed using Prism software;
the difference between wild-type and mutant or between the
various treatments was compared using ANOVA. P values,0.05
were considered significant. All experiments were carried out on 3
or more occasions with cultures obtained from independent mouse
litters.
Expression constructs
For knockdown of Oxr1 expression, a Mission shRNA construct
(Sigma) specific to all TLDc-containing isoforms of the gene (see
Figure S7) was used. Primary cells were electroporated with
constructs using the Amaxa Nucleofector method (Lonza). The
relative level of knockdown was consistently over 90% as shown by
qRT-PCR using Oxr1 exon-spanning primers (Figure S4B). For
over-expression of Oxr1, the full-length mouse coding sequence
(NM_130885) with a C-terminal HA-tag was cloned into pLenti6/
V5-D-TOPO vector (Invitrogen) with a stop codon introduced
before the V5 sequence. The constructs were transfected into
HEK293T cells with packaging vectors and virus-containing
supernatants were collected 3 days later. GCs were infected after
11 days in culture by adding lentivirus-containing medium (1:50
dilution) and H2O2 treatment was carried out after 3 days of
infection for 4 hours prior to cell survival estimation as above.
Lentiviral Oxr1 expression equivalent to endogenous levels were
consistently obtained as shown by qRT-PCR using Oxr1 primers
as above (Figure S4B). For over-expression studies comparing
Oxr1-FL and Oxr1-C sequences, the coding regions (NM_130885
and NM_001130164, respectively) were cloned into a bicistronic
pCAGGS-based vector with additional internal ribosomal entry
site (IRES) upstream of GFP. Primary cells were electroporated as
above.
Western blotting
Tissue or cell extracts were prepared using standard RIPA
buffer and protein levels were quantified using BSA assays (Pierce
Thermo Scientific). After primary antibody (Oxr1 1:100 (see
above); catalase (Abcam); Gpx1 (Epitomics); SOD1 (Abcam)) and
peroxidase-conjugated secondary antibody incubation, blots were
developed with the ECL kit (Amersham). Frozen thoracic spinal
cord samples from non-SOD-related sporadic ALS patients and
age-matched controls were obtained from the Thomas Willis
Oxford Brain Collection. The lumbar enlargement of the spinal
cord from 5-month old male SOD1 G93A mutants (TgN[SOD1*-
G93A]Gur1) and littermate wild-type controls were dissected and
protein extracts prepared immediately as above. Band intensity
relative to internal controls was carried out using ImageJ software.
Quantitative RT–PCR
Expression studies were carried out from total RNA purified
using the RNeasy kit (Qiagen). cDNA was generated using Expand
Reverse Transcriptase (Roche) and triplicate qRT-PCR reactions
carried out using SYBR green (Applied Biosystems). Data were
analysed using StepOne software (Applied Biosystems) and
normalised to the control b-actin gene in all cases. All data shown
are generated from at least 3 independent samples. Primer
sequences are shown in Dataset S1.
Generation of Oxr1 transgenic line
The full-length mouse Oxr1 coding sequence was cloned into a
pCAGGS-derived vector (containing the chicken b-actin promoter
with a CMV enhancer and a rabbit b-globin intron), freed of the
plasmid backbone by restriction digest and injected into the
pronuclei of superovulated CBAB6F1 mice. Founder mice were
initially identified usingOxr1 exon-spanning primers for subsequent
breeding. Two independent founder females (Tg(CAG-Oxr1)+/2) were
bred to heterozygous bel/+ males over two generations to generate
mice homozygous for the bel deletion but also expressing the Oxr1
transgene (bel/bel, Tg(CAG-Oxr1)+/2) to determine genetic rescue.
Genetic background effects were controlled by assessing the onset of
ataxia and neuropathology of non-transgenic bel/bel mutants which
proved to be identical to the original bel line.
Generation of the Oxr1 gene-trap line
Gene-trap ES cell line RRR195 (Oxr1Gt(RRR195)Byg) was
obtained from Bay Genomics and the correct identity of the
insertion was confirmed by RT-PCR from cultured cells prior to
rederivation. RRR195 ES cells were injected into preimplantation
mouse embryos and chimeras were generated and bred with
C57BL/6J mice. Chimera ES cell contribution and germline
transmission were assessed by coat colour and confirmed by
genotyping. The exact position of the insertion was determined by
PCR to generate primers for genotyping; 59 GTGTTGAGT-
TCCCCATC and 59 CCGCAAACTCCTATTTCTGAG for the
gene-trap vector or 59 CAATCTAAATCCACTGCTGAC for the
wild-type intron 3/4 control. Mice heterozygous for the insertion
were bred together to generate homozygous animals.
Recombinant Oxr1 protein purification and antibody
production
The full-length coding sequence of Oxr1-C (NM_001130164)
and a region representing the TLDc domain of mouse Oxr1 (C7C,
see Figure S7) were subcloned into the pET-22b(+) expression
vector (Novagen) in-frame with a polyhistidine tag (66His) at the
C-terminus. The coding sequence of mouse DJ-1 (NM_020569)
was cloned in the same manner. Oxr1 cysteine mutants were
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generated by QuikChange site-directed mutagenesis (Stratagene)
and sequenced prior to use. Constructs were transformed into
BL21(DE3) E.Coli cells (Invitrogen) and protein expression was
induced overnight at 18uC at O.D600,0.8 by addition of
isopropyl-b-D-thiogalactopyranoside (IPTG) to a final concentra-
tion of 0.1 mM (Oxr1) or 0.25 mM (DJ-1). Bacterial cultures were
sonicated and recombinant His-tagged proteins were purified from
the soluble fraction using BD Talon metal affinity resin (BD
Biosciences Clontech) according to the manufacturer’s recom-
mendations. Antiserum was raised in rabbits against the C7C
TLDc domain fusion protein (Eurogentec) and affinity purified.
For protein oxidation studies, proteins were reduced in 2 mM
DTT and subjected to buffer exchange into 50 mM phosphate
buffer, pH 7.4 on PD-10 filtration columns (GE Healthcare) prior
to use.
Amplex Red assay
The Amplex Red assay was used to determine the presence
and/or depletion of H2O2 essentially as described by the
manufacturer (Molecular Probes). Working solutions of the dye
and horseradish peroxidase (HRP) were made fresh for each assay
and added to varying amounts of purified recombinant protein.
Based on predicted molecular weight of Oxr1-C (28.55 kDa),
protein concentrations ranged from 0.175 to 1.4 mM. The reaction
was initiated with the addition of H2O2 at a final concentration of
1.4 mM (e.g. ratio of H2O2 to Oxr1-C of up to 1:1). Samples were
incubated for 30 minutes at 37uC in the dark and fluorescence
readings were obtained at 580 nm. All wells were counted in
triplicate correcting for background fluorescence from a blank
sample and all experiments were repeated on 3 separate occasions.
Labelling of free SH groups with ThioGlo-1
Pre-reduced recombinant Oxr1-C protein was incubated with
100 mM H2O2 (final concentration) at 37uC for up to 30 minutes.
Individual aliquots (corresponding to 5 mg of protein) were taken at
a range of timepoints, excess H2O2 was removed with purified
catalase (Sigma), and the amount of reactive thiols determined by
incubation with 30 mMThioGlo-1 for 90 minutes at 60uC. Samples
were mixed with Laemmli loading dye (without bromophenol blue
to prevent background fluorescence) and subjected to SDS-PAGE.
Gels were visualised with an ultraviolet light source and subjected to
densitometry using a Fluor-S MultiImager (BioRad). To confirm
equal loading of protein, gels were post-stained using SimplyBlue
(Invitrogen). The rate constant for this reaction was estimated by
plotting (1/nHo2So) ln[So(Ho2S)/Ho(So2nS)] versus time as
previously described [40], where Ho represents the initial
concentration of H2O2, So is the initial concentration of free SH
groups, S is the SH content reacted and n is the moles of free SH
oxidised per mole of H2O2; n was taken to be a value of 2 given two
potential reactive cysteines in the Oxr1-C recombinant protein
fragment used.
Catalase and Gpx assays
Catalase activity from cerebellar tissue samples was carried out
using Amplex Red Catalase Assay Kit (Molecular Probes) and
Gpx activity was measured using the Glutathione Peroxidase
Assay Kit (Calbiochem), both according to the manufacturer’s
instructions based on standard curves of enzyme activity.
DNA fragmentation assay
Genomic DNA from cells was extracted using the Genomic
DNA Extraction Kit for tissues (Qiagen). Double-stranded DNA
was quantified using PicoGreen (Thermo Scientific) as per
manufacturer’s instructions and compared to a standard curve
generated from l/HindIII DNA to determine a ratio of dsDNA to
ssDNA (strand scission factor) in the sample.
Supporting Information
Dataset S1 Primers used for qRT-PCR of oxidative stress
markers.
(DOC)
Figure S1 Quantitative histological analysis of the bel cerebellum
andmuscle. (A) Cresyl violet staining of a vermal parasagittal section
indicates that no disruption in the foliation of the bel cerebellum
occurs. A small but non-significant reduction in cerebellar size is
observed in bel mice compared to controls, based on area
calculations from multiple sections (D). The size of the bel
cerebellum in not proportionally smaller than controls, however
(E). (B) Cresyl violet staining of lobe IV/V indicating the position of
the cerebellar granule cell (GCL), molecular (ML) and Purkinje cell
(PCL) layers. A small but non-significant reduction in average GCL
width is observed in bel mice compared to controls in lobes III, IV/
V and IX; data for lobe IV/V are shown (F). (C) Adjacent sections
were immunostained with anti-calbindin and used to calculate the
average Purkinje cell density in belmice. There was no difference in
density between the genotypes showing no cell death in the PCL in
bel mice (G). (H) Haematoxylin and eosin staining of representative
transverse sections of bel and wild-type (+/+) diaphragm muscle
indicating centrally nucleated fibres in mutants (arrowheads). (I)
Quantification of centrally nucleated fibres in the soleus, TA and
diaphragm from all genotypes (**P,0.01, ANOVA). Scale bars:
0.5 mm (A) and 0.1 mm in (B) and (C).
(TIF)
Figure S2 Identification of the bel deletion. (A) Annotation of
mouse chromosome 15 showing the critical mapped genetic region
for the bel phenotype. The exact position of the deletion as
determined by inverse PCR as indicated, and confirmed by PCR
using flanking primers (B).
(TIF)
Figure S3 Additional expression analysis of Oxr1 and Abra. (A) In
situ hybridisation showing expression of Oxr1 but not Abra in wild-
type spinal cord at P24. The same Abra riboprobe detects
expression of the gene in skeletal muscle (B). (C) Gene structure
of full-length Oxr1 (Oxr1-FL) and short Oxr1 (Oxr1-C) isoforms,
not to scale; exon 9 is unique to Oxr1-C. (D) RT-PCR of the
entire protein-coding sequence of Oxr1-FL, Oxr1-C and Abra from
P24 brain (lanes labelled B) and cerebellum (lanes labelled C)
tissue. Skeletal muscle (M) is also shown as a positive control for
Abra expression. Note that the two bands amplified using Oxr1-C
primers correspond to transcripts either containing (Oxr1-C) or
lacking (Oxr1-C9) the alternatively spliced exon 10. Negative
control reactions from template containing no RT enzyme are
indicated (2). (E) In situ hybridisation of adult (P56) mouse brain
using riboprobes specific to Oxr1-FL and Oxr1-C. For details of
the relative probe positions, see Figure S7.
(TIF)
Figure S4 Primary neuronal culture control data. (A) Gradient
of H2O2 treatment tested in primary GCs to generate a robust
stress response for apoptotic cell counts. (B) Quantitative RT-PCR
of relative total Oxr1 expression level after knockdown and
lentiviral over-expression from 3 independent experiments. (C)
Immunostaining of GCs and N2A cells using the Oxr1 antibody
demonstrates induction and co-localisation of Oxr1 with the cox4
mitochondrial marker 1 hour after peroxide treatment.
(TIF)
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Figure S5 Oxidative stress markers in bel cerebellum. (A)
Quantitative RT-PCR from end-stage bel and wild-type littermate
cerebellum tissue for a range of oxidative stress makers: catalase
(cat), cullin1 (cul1), cytochrome c (cytc), glutamate-cysteine ligase
catalytic and modifier subunits (gclc/gclm), glial fibrillary acidic
protein (gfap), glutathione peroxidise 1 (gpx1), heme oxygenase 1
(ho1), kelch-like ECH-associated protein 1 (keap1), NAD(P)H
dehydrogenase, quinone 1 (nqo1), nuclear factor (erythroid-derived
2)-like 2 (nrf2), Peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (pgc1a), superoxide dismutase 1 and 2 (Sod1
and Sod2). Data are also shown as relative expression ratio between
genotypes for key antioxidant enzymes (B), including a significant
reduction in gpx1 expression in mutants (*** P,0.01, ANOVA).
(C) No difference in the protein levels of catalase, Gpx1 or SOD1
is observed in cerebellar tissue between end-stage bel and littermate
control mice as shown by western blot. Enzyme assays also show
no difference in the activity of Gpx (D) or catalase (E) from the
same tissue.
(TIF)
Figure S6 Serum starvation of GCs. Primary GCs from wild-
type and bel mice were cultured for 14 days were subjected to
serum starvation for 4 hours. No difference in apoptosis was
observed between genotypes.
(TIF)
Figure S7 Diagram of cDNAs and probes used. cDNA
structures of mouse Oxr1-FL and Oxr1-C (not to scale) with
relative positions of probes/antibodies used in this study. The
structure of the gene-trap cDNA is also shown.
(TIF)
Figure S8 Protein purification of Oxr1 and C-terminal sequence
alignment. (A) Coomassie staining of SDS-PAGE gels showing the
induction (left) and subsequent purification (right, 5 mg loading) of
wild-type and mutant histidine-tagged Oxr1-C and DJ-1 proteins.
The position of the mutated cysteine amino acids in the TLDc
domain refers to full-length mouse Oxr1 protein sequence
(accession number NP_570955). (B) ClustalW alignment of the
C-terminal region of the TLDc domain in Oxr1-related proteins
from Homo sapiens (hs), Mus musculus (mm), Xenopus laevis (xl), Danio
rerio (dr), Drosophila melanogaster (dm) and Saccharomyces cerevisiae (sc).
Position of the cysteine residue C753 in mouse Oxr1 is marked.
The alanine residue in TBC1D24 recently reported as mutated in
human FIME (A509V) is highlighted in yellow.
(TIF)
Video S1 Film demonstrating the phenotype of the belmutant. A
bel male mouse at P24 is shown, later joined by a heterozygous
(bel/+) littermate.
(WMV)
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